Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 143M 423M 124M 114M 107M 200M 13.66B 204M 1.36B 527M 6.58B 536M 524M 22.89B | P/E Ratio 2024 |
-4.01x | P/E Ratio 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 279M 827M 242M 223M 209M 391M 26.71B 399M 2.66B 1.03B 12.88B 1.05B 1.02B 44.77B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
73.95% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 24/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 01/03/2020 |
Itai Kabiljo
LAW | General Counsel | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 03/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 14/12/2014 |
| Chairman | 55 | 13/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 47.47M | |
| +2.70% | +0.66% | -24.00% | -33.33% | 150M | |
| -1.81% | -2.40% | +40.52% | +64.65% | 118M | |
| -5.45% | -10.34% | +85.71% | -26.76% | 112M | |
| -0.01% | -0.78% | +70.76% | +7.33% | 98.89M | |
| Average | -0.87% | +2.71% | +43.25% | +2.97% | 119.47M | |
| Weighted average by Cap. | -0.78% | +2.39% | +37.14% | +0.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 708M 207M 191M 179M 334M 22.87B 341M 2.28B 882M 11.02B 897M 877M 38.33B | 270M 800M 234M 216M 203M 378M 25.87B 386M 2.58B 998M 12.47B 1.01B 992M 43.36B |
| Net income | -67.8M -201M -58.83M -54.23M -50.81M -94.94M -6.49B -96.92M -647M -250M -3.13B -255M -249M -10.88B | -35.71M -106M -30.99M -28.57M -26.77M -50.01M -3.42B -51.05M -341M -132M -1.65B -134M -131M -5.73B |
| Net Debt | 133M 393M 115M 106M 99.5M 186M 12.71B 190M 1.27B 490M 6.13B 498M 488M 21.3B | 136M 404M 118M 109M 102M 191M 13.05B 195M 1.3B 504M 6.29B 512M 501M 21.88B |
Employees
-
